Tranexamic Acid 500 mg, Mefenamic Acid 250 mg Tablet (FC) Use, Indications, Side Effects, Dosage, Mechanism of Action, Price, Contra Indications, Drug Interactions.
PACK: 10 Tablet
MRP: 269.00
TREV MF Tablet is a pharmaceutical product from Green Cross Remedies, combining Tranexamic Acid (500 mg) and Mefenamic Acid (250 mg). This effective formulation is designed to alleviate menstrual pain and heavy bleeding. It works by reducing blood loss and relieving pain associated with dysmenorrhea. Available at an affordable price, TREV MF is a reliable choice for women seeking relief from menstrual discomfort. Always consult your healthcare provider for proper dosage, potential side effects, and contraindications.
Composition:
Uses and Indications of TREV MF Tablet-Tranexamic Acid 500 mg, Mefenamic Acid 250 mg
Uses:
TREV MF Tablet combines two active ingredients, Tranexamic Acid and Mefenamic Acid, to provide effective relief in the following conditions:
Indications:
The primary indications for the use of TREV MF Tablet include:
Mechanism of Action:
Tranexamic Acid acts by inhibiting the breakdown of fibrin in blood clots, thus reducing blood loss, while Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that alleviates pain by reducing inflammation.
Dosage:
The recommended dosage should be determined by a healthcare professional based on individual needs. Typically, it is taken at the onset of menstrual pain.
Side Effects:
Common side effects may include nausea, diarrhea, and dizziness. Consult a physician if you experience severe side effects.
Contraindications:
Do not use TREV MF Tablet if you have a history of gastrointestinal bleeding, severe renal impairment, or are allergic to any of its components.
Drug Interactions:
Inform your doctor about all medications you are taking, as TREV MF may interact with anticoagulants, NSAIDs, or other medications.
Disclaimer:
This information is intended for the use of Registered Medical Practitioners, Hospitals, Pharmaceutical Company Field Staff, and Pharmacies Only.